[TNGX] QoQ Quarter Result on 31-Dec-2021 [#Q4]

Stock
[TNGX] Tango Therapeutics, Inc.
Announcement Date
28-Mar-2022
Financial Year
2021
Quarter
31-Dec-2021 [#Q4]
Profit Trend
QoQ- -12.54%
YoY- -148.71%
Quarter Report
TNGX's Result
TNGX's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Revenue 6,920 5,771 5,758 5,716 6,787 18,153 6,386 5.49%
PBT -29,050 -24,855 -25,208 -21,869 -19,528 -4,514 -12,032 79.87%
Tax -873 3 -171 177 62 -21 74 -
NP -28,177 -24,858 -25,037 -22,046 -19,590 -4,493 -12,106 75.53%
Tax Rate - - - - - - - -
Total Cost 35,097 30,629 30,795 27,762 26,377 22,646 18,492 53.23%
Ratio Analysis
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
NP Margin -407.18 -430.74 -434.82 -385.69 -288.64 -24.75 -189.57 66.39%
Per Share
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
EPS -0.32 -0.28 -0.29 -0.25 -0.28 -0.05 -0.14 73.43%
EPS Diluted -0.32 -0.28 -0.29 -0.25 -0.28 -0.05 -0.14 73.43%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.